Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin and tolterodine for ureteral stent related symptoms
IRCT201111255786N2Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences (Vice Chancellor for Research)
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of terazosin and tolterodine in ureteral stent-related symptoms (USRS), sponsored by Urmia University of Medical Sciences (Vice Chancellor for Research). Started Dec 2011; status: completed.
02
Drugs
terazosintolterodine
03
Conditions
ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on IRCT201111255786N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201111255786N2.